In a report released yesterday, Steven Lichtman from Oppenheimer assigned a Hold rating to Wright Medical Group (NASDAQ: WMGI). The company’s shares closed yesterday at $25.78.
According to TipRanks.com, Lichtman has 0 stars on 0-5 star ranking scale with an average return of -3.1% and a 53.7% success rate. Lichtman covers the Healthcare sector, focusing on stocks such as Motus Gi Holdings Inc, Integra Lifesciences, and K2M Group Holdings.
Wright Medical Group has an analyst consensus of Moderate Buy, with a price target consensus of $30.
See today’s analyst top recommended stocks >>
Based on Wright Medical Group’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $19.91 million. In comparison, last year the company had a GAAP net loss of $36.71 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Wright Medical Group NV operates as a global medical device company, which engages in the design, manufacture, and distribution of biologic products. It provides surgical solutions for the foot and ankle market and its products include large joint implants for the hip and knee, extremity implants for the shoulder, elbow, hand, wrist and foot and biologic products, including bone graft substitutes. The company was founded by Frank O. Wright in 1950 and is headquartered in Arlington, TN.
